This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Chowdary KV, Reddy PN. Parenteral nutrition: Revisited. Indian J Anaesth. 2010; 54: 95–103.ChowdaryKVReddyPNParenteral nutrition: Revisited20105495103Search in Google Scholar
Stueck AE. Intestinal failure-associated liver disease: Risks and regression. Liver Int. 2018; 38: 35–37.StueckAEIntestinal failure-associated liver disease: Risks and regression2018383537Search in Google Scholar
Tillman EM. Review and clinical update on parenteral nutrition-associated liver disease. Nutr Clin Pract. 2013; 28: 30–39.TillmanEMReview and clinical update on parenteral nutrition-associated liver disease2013283039Search in Google Scholar
Mitra A, Ahn J. Liver disease in patients on total parenteral nutrition. Clin Liver Dis. 2017; 21: 687–695.MitraAAhnJLiver disease in patients on total parenteral nutrition201721687695Search in Google Scholar
Lloyd DA, Gabe SM. Managi liver dysfunction in parenteral nutrition. Proc Nutr Soc 2007; 66: 530–538.LloydDAGabeSMManagi liver dysfunction in parenteral nutrition200766530538Search in Google Scholar
Reimann F, Tolhurst G, Gribble FM. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012; 15: 421–431.ReimannFTolhurstGGribbleFMG-protein-coupled receptors in intestinal chemosensation201215421431Search in Google Scholar
Furness JB. Integrated neural and endocrine control of gastrointestinal function. Adv Exp Med Biol. 2016; 891: 159–173.FurnessJBIntegrated neural and endocrine control of gastrointestinal function2016891159173Search in Google Scholar
Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease. Diabetes Obes Metab. 2018; 20 Suppl 1: 5–21.NauckMAMeierJJIncretin hormones: Their role in health and disease201820Suppl 1521Search in Google Scholar
Wales PW, Allen N, Worthington P, George D, Compher C, the American Society for Parenteral and Enteral Nutrition, Teitelbaum D. A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. J Parenter Enteral Nutr. 2014; 38: 538–557.WalesPWAllenNWorthingtonPGeorgeDCompherCthe American Society for Parenteral and Enteral NutritionTeitelbaumDA.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease201438538557Search in Google Scholar
Cao X, Feng F, Liu X, Sun C, Yang X, Fang Y, Li S. Exogenous secretin improves parenteral nutrition-associated liver disease in rats. Journal of Pediatric Gastroenterology and Nutrition. 2020; 70: 430–435.CaoXFengFLiuXSunCYangXFangYLiSExogenous secretin improves parenteral nutrition-associated liver disease in rats202070430435Search in Google Scholar
Olveira G, Tapia MJ, Ocón J, Cabrehas-Gomez C, Ballesteros-Pomar MD, Vidal-Casariego A, Arraiza-Irigoyen C, Olivares J, Conde-Carcia MC, Garcia-Manzanares A, et al. Hypoglycemia in noncritically ill patients receiving total parenteral nutrition: a multicenter study. (Study group on the problem of hyperglycemia in parenteral nutrition; Nutrition area of the Spanish Society of Endocrinology and Nutrition). Nutrition. 2015; 31: 58–63.OlveiraGTapiaMJOcónJCabrehas-GomezCBallesteros-PomarMDVidal-CasariegoAArraiza-IrigoyenCOlivaresJConde-CarciaMCGarcia-ManzanaresAHypoglycemia in noncritically ill patients receiving total parenteral nutrition: a multicenter study. (Study group on the problem of hyperglycemia in parenteral nutrition; Nutrition area of the Spanish Society of Endocrinology and Nutrition)2015315863Search in Google Scholar
McCulloch A, Bansiya V, Woodward JM. Addition of insulin to parenteral nutrition for control of hyperglycemia. JPEN J Parenter Enteral Nutr. 2018; 42: 846–854.McCullochABansiyaVWoodwardJMAddition of insulin to parenteral nutrition for control of hyperglycemia201842846854Search in Google Scholar
Lou PH, Lucchinetti E, Wawrzyniak P, Morsy Y, Wawrzyniak M, Scharl M, Kramer S, Rogler G, Herberger M, Zaugg M. Choice of lipid emulsion determines inflammation of the gut-liver axis, incretin profile, and insulin signaling in a murine model of total parenteral. Mol Nutr Food Res. 2021; 65: e2000412.LouPHLucchinettiEWawrzyniakPMorsyYWawrzyniakMScharlMKramerSRoglerGHerbergerMZauggMChoice of lipid emulsion determines inflammation of the gut-liver axis, incretin profile, and insulin signaling in a murine model of total parenteral202165e2000412Search in Google Scholar
Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest. 2007; 117: 24–32.DruckerDJThe role of gut hormones in glucose homeostasis20071172432Search in Google Scholar
Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007; 87: 1409–1439.HolstJJThe physiology of glucagon-like peptide 120078714091439Search in Google Scholar
Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010; 90: 859–904.SekirovIRussellSLAntunesLCFinlayBBGut microbiota in health and disease201090859904Search in Google Scholar
De Minicis S, Rychlicki C, Agostinelli L, Saccomanna S, Candelaresi C, Trozzi L, Mingarelli E, Facinella B, Magi G, Palmieri C, et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology. 2014; 59: 1738–1749.De MinicisSRychlickiCAgostinelliLSaccomannaSCandelaresiCTrozziLMingarelliEFacinellaBMagiGPalmieriCDysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice20145917381749Search in Google Scholar
Pierre JF. Gastrointestinal immune and microbiome changes during parenteral nutrition. Am J Physiol Gastrointest. Liver Physiol. 2017; 312: G246–G256.PierreJFGastrointestinal immune and microbiome changes during parenteral nutrition2017312G246G256Search in Google Scholar
Zaloga GP. Lipid administration, and liver disease during parenteral nutrition. JPEN J Parenter Enteral Nutr. 2015; 39: 39S–60S.ZalogaGPLipid administration, and liver disease during parenteral nutrition20153939S60SSearch in Google Scholar
Wildhaber BE, Yang H, Spencer AU, Drongowski RA, Teitelbaum DH. Lack of enteral nutrition—Effects on the intestinal immune system. J Surg Res. 2005; 123: 8–16.WildhaberBEYangHSpencerAUDrongowskiRATeitelbaumDHLack of enteral nutrition—Effects on the intestinal immune system2005123816Search in Google Scholar
Cerovic V, Bain CC, Mowat AM, Milling SW. Intestinal macrophages and dendritic cells: What's the difference? Trends Immunol. 2014; 35: 270–277.CerovicVBainCCMowatAMMillingSWIntestinal macrophages and dendritic cells: What's the difference?201435270277Search in Google Scholar
Ochi T, Feng Y, Kitamoto S, Nagao-Kitamoto H, Kuffa P, Atarashi K, Honda K, Teitelbaum DH, Kamada N. Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine. Sci Rep. 2016; 6: 27634.OchiTFengYKitamotoSNagao-KitamotoHKuffaPAtarashiKHondaKTeitelbaumDHKamadaNDiet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine2016627634Search in Google Scholar
Lespine A, Fernandez Y, Periquet B, Galinier A, Garcia J, Anglade F, Ghisolfi J, Thouvenot JP. Total parenteral nutrition decreases liver oxidative metabolism and antioxidant defenses in healthy rats: comparative effect of dietary olive and soybean oil. JPEN J Parenter Enteral Nutr. 2001; 25: 52–59.LespineAFernandezYPeriquetBGalinierAGarciaJAngladeFGhisolfiJThouvenotJPTotal parenteral nutrition decreases liver oxidative metabolism and antioxidant defenses in healthy rats: comparative effect of dietary olive and soybean oil2001255259Search in Google Scholar
Rochling FA. Intravenous lipid emulsions in the prevention and treatment of liver disease in intestinal failure. Nutrients. 2021; 13: 895.RochlingFAIntravenous lipid emulsions in the prevention and treatment of liver disease in intestinal failure202113895Search in Google Scholar
Gabe SM. Lipids and liver dysfunction in patients receiving parenteral nutrition. Curr Opin Clin Nutr Metabol Care. 2013; 16: 150–155.GabeSMLipids and liver dysfunction in patients receiving parenteral nutrition201316150155Search in Google Scholar
Xu ZW, Li YS. Pathogenesis and treatment of parenteral nutrition-associated liver disease. Hepatobiliary Pancreat Dis Int. 2012; 11: 586–593.XuZWLiYSPathogenesis and treatment of parenteral nutrition-associated liver disease201211586593Search in Google Scholar
Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schutz T, Plauth M. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr. 2020; 39: 3533–3562.BischoffSCBernalWDasarathySMerliMPlankLDSchutzTPlauthMESPEN practical guideline: Clinical nutrition in liver disease20203935333562Search in Google Scholar
Lidder PG, Lewis S. Perioperative and postoperative nutrition. Hosp Med. 2004; 65: 717–720.LidderPGLewisSPerioperative and postoperative nutrition200465717720Search in Google Scholar
Norsa L, Nicastro E, Di Giorgio A, Lacaille F, D'Antiga L. Prevention and treatment of intestinal failure-associated liver disease in children. Nutrients. 2018; 10: 664.NorsaLNicastroEDi GiorgioALacailleFD'AntigaLPrevention and treatment of intestinal failure-associated liver disease in children201810664Search in Google Scholar
Demehri FR, Stephens L, Herrman E, West B, Mehringer A, Arnold MA, Brown PI, Teitelbaum DH. Enteral autonomy in pediatric short bowel syndrome: predictive factors one year after diagnosis. J Pediatr Surg. 2015; 50: 131–135.DemehriFRStephensLHerrmanEWestBMehringerAArnoldMABrownPITeitelbaumDHEnteral autonomy in pediatric short bowel syndrome: predictive factors one year after diagnosis201550131135Search in Google Scholar
Hwang T, Lue M, Chen L. Early use of cyclic TPN prevents further deterioration if liver functions for the TPN patient with impaired liver function. Hepatogastroenterology. 2004; 47: 1347–1350.HwangTLueMChenLEarly use of cyclic TPN prevents further deterioration if liver functions for the TPN patient with impaired liver function20044713471350Search in Google Scholar
Calder P. Hot topics in parenteral nutrition: Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc. 2009; 68: 252–260.CalderPHot topics in parenteral nutrition: Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults200968252260Search in Google Scholar
Mundi M, Salonen B, Bonnes S. Home parenteral nutrition: fat emulsions and potential complications. Nutr Clin Pract. 2016; 31: 629–641.MundiMSalonenBBonnesSHome parenteral nutrition: fat emulsions and potential complications201631629641Search in Google Scholar
Bharadwaj S, Gohel T, Deen OJ, DeChicco R, Shatnawei A. Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease. Gastroenterol Rep (Oxf). 2015; 3: 110–114.BharadwajSGohelTDeenOJDeChiccoRShatnaweiAFish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease20153110114Search in Google Scholar
Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004; 111: 611–616.HellerARRosselTGottschlichBTiebelOMenschikowskiMLitzRJZimmermannTKochTOmega-3 fatty acids improve liver and pancreas function in postoperative cancer patients2004111611616Search in Google Scholar
Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132: 525–532.CavicchiMBeauPCrennPDegottCMessingBPrevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure2000132525532Search in Google Scholar
Meisel JA, Le HD, de Meijer VE, Nose V, Gura KM, Mulkern RV, Sharif MRA, Puder M. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg. 2011; 46: 666–673.MeiselJALeHDde MeijerVENoseVGuraKMMulkernRVSharifMRAPuderMComparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model201146666673Search in Google Scholar
El Kasmi KC, Anderson AL, Devereaux MW, Vue PM, Zhang W, Setchell KD, Karpen SJ, Sokol RJ. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med. 2013; 5: 137.El KasmiKCAndersonALDevereauxMWVuePMZhangWSetchellKDKarpenSJSokolRJPhytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease20135137Search in Google Scholar
Mateu de Antonio J, Florit-Sureda M. Effects unrelated to anti-inflammation of lipid emulsions containing fish oil in parenteral nutrition for adult patients, Nutr Hosp. 2017; 34: 193–203.Mateu de AntonioJFlorit-SuredaMEffects unrelated to anti-inflammation of lipid emulsions containing fish oil in parenteral nutrition for adult patients201734193203Search in Google Scholar
Ng K, Stoll B, Chacko S, de Pipaon MS, Lauridsen C, Gray M, Squires EJ, Marini J, Zamora IJ, Olutoye OO. Vitamin E in new-generation lipid emulsions protects against parenteral nutrition-associated liver disease in parenteral nutrition-fed preterm pigs. JPEN J Parenter Enteral Nutr. 2016; 40: 656–671.NgKStollBChackoSde PipaonMSLauridsenCGrayMSquiresEJMariniJZamoraIJOlutoyeOOVitamin E in new-generation lipid emulsions protects against parenteral nutrition-associated liver disease in parenteral nutrition-fed preterm pigs201640656671Search in Google Scholar
Guthrie G, Stoll B, Chacko S, Lauridsen C, Plat J, Burrin D. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets. Am J Physiol Gastrointest Liver Physiol. 2020; 318: G41–G52.GuthrieGStollBChackoSLauridsenCPlatJBurrinDRifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets2020318G41G52Search in Google Scholar
Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J, Ament ME. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology; 22: 1399–1403.BuchmanALDubinMDMoukarzelAAJendenDJRochMRiceKMGornbeinJAmentMECholine deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation2213991403Search in Google Scholar
Matsukubo M, Yano K, Kaji T, Sugita K, Onishi S, Harumatsu T, Nagano A, Matsui M, Murakami M, Yamada K. The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model. Pediatr Surg Int. 2021; 37: 353–361.MatsukuboMYanoKKajiTSugitaKOnishiSHarumatsuTNaganoAMatsuiMMurakamiMYamadaKThe administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model202137353361Search in Google Scholar
Feng Y, Demehri FR, Xiao W, Tsai Y, Jones J, Brindley CD, Treadgill DW, Holst JJ, Hartmann B, Barrett TA, et al. Interdependency of EGF and GLP-2 signaling in attenuating mucosal atrophy in a mouse model of parenteral nutrition. Cell Mol Gastroenterol Hepatol. 2017; 3: 447–468.FengYDemehriFRXiaoWTsaiYJonesJBrindleyCDTreadgillDWHolstJJHartmannBBarrettTAInterdependency of EGF and GLP-2 signaling in attenuating mucosal atrophy in a mouse model of parenteral nutrition20173447468Search in Google Scholar
Ceulemans LJ, Verbeke L, Decuypere JP, Farre R, De Hertogh G, Lenaerts K, Jochmans I, Monbaliu D Nevens F, Tack J, et al. Farnesoid X receptor activation attenuates intestinal ischemia reperfusion injury in rats. PLoS One. 2017; 12: e0169331.CeulemansLJVerbekeLDecuypereJPFarreRDe HertoghGLenaertsKJochmansIMonbaliu D NevensFTackJFarnesoid X receptor activation attenuates intestinal ischemia reperfusion injury in rats201712e0169331Search in Google Scholar
Liu Y, Xiao Y, Chen S, Tian X, Wang W, Wang Y, Cai W. The farnesoid X receptor agonist tropifexor prevents liver damage in parenteral nutrition-fed neonatal piglets. J Pediatr Gastroenterol Nutr. 2021; 73: e11–e19.LiuYXiaoYChenSTianXWangWWangYCaiWThe farnesoid X receptor agonist tropifexor prevents liver damage in parenteral nutrition-fed neonatal piglets202173e11e19Search in Google Scholar
Morin G, Guiraut C, Perez Marcogliese M, Mohamed I, Lavoie JC. Glutathione supplementation of parenteral nutrition prevents oxidative stress and sustains protein synthesis in guinea pig model. Nutrients. 2019. 3; 11: 2063.MorinGGuirautCPerez MarcoglieseMMohamedILavoieJCGlutathione supplementation of parenteral nutrition prevents oxidative stress and sustains protein synthesis in guinea pig model20193112063Search in Google Scholar
Song E, Nagarapu A, van Nispen J, Armstrong A, Manithody C, Murali V, Voigt M, Samaddar A, Hutchinson C, Jain S, Roenker J, Krebs J, Jain AK. Carbamazepine mitigates parenteral nutrition–associated liver disease in a novel ambulatory piglet model. JPEN J Parenter Enteral Nut. 2022 Aug; 46: 1384–1392.SongENagarapuAvan NispenJArmstrongAManithodyCMuraliVVoigtMSamaddarAHutchinsonCJainSRoenkerJKrebsJJainAKCarbamazepine mitigates parenteral nutrition–associated liver disease in a novel ambulatory piglet model2022Aug4613841392Search in Google Scholar
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003; 124: 1111–1134.BuchmanALScolapioJFryerJAGA technical review on short bowel syndrome and intestinal transplantation200312411111134Search in Google Scholar
Fryer J, Pellar S, Ormond D, Koffron A, Abecessis M. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl. 2003; 9: 748–753.FryerJPellarSOrmondDKoffronAAbecessisMMortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants20039748753Search in Google Scholar